Register for email alerts and news feeds:
This journal | BMJ Group
rss
The most recent version of this article was published on 1 February 2006

Gut. Published Online First: 15 November 2005. doi:10.1136/gut.2005.064980
Copyright © 2005 BMJ Publishing Group Ltd & British Society of Gastroenterology.

Paper

Treatment of pancreatic carcinoma by adenoviral mediated gene transfer of vasostatin in mice

Lei Li 1, Yaozong Yuan 1*, Jian Lu 2, Lu Xia 1, Ying Zhu 1, Yongping Zhang 1 and Minmin Qiao 1

1 Department of Gastroenterology, Ruijin Hospital, Shanghai Second Medical University, China
2 Department of Biochemistry and Center of Human Gene Therapy, Shanghai Second Medical University, China

* To whom correspondence should be addressed. E-mail: yyz28{at}medmail.com.cn.

Accepted 28 September 2005


Abstract

Background: Tumor growth is angiogenesis- dependent and antiangiogenesis therapy may represent a promising therapeutic option.

Aims: To evaluate the inhibitory effect of vasostatin gene mediated by a replication-deficient recombinant adenovirus on human pancreatic cancer in vivo and to investigate the mechanism of vasostatin.

Methods: Human umbilical vein endothelium derived ECV304 cells were infected with Ad-vasostatin and Ad- lacZ, compared with PBS. MTT assay was used to estimate the proliferation of ECV304 cells; tube formation assay and choriallantoic membrance assay were used to evaluate angiogenesis in vitro and in vitro. The xenografted nude mice with pancreatic cancer were established to observe the in vivo tumor growth suppression. The microvessel density revealed by CD31 immunohistochemical staining was measured.

Results: The growth and tube formation of ECV304 cells infected with Ad-vasostatin was suppressed significantly compared with that of cells infected with Ad-lacZ or cells treated with PBS. The neovascularization in Ad-vasostatin group was less than these in PBS group and in Ad-lacZ group according to the CAM results. The volumes of pancreastic tumors in Ad- vasostatin group were smaller significantly than these in PBS group and in Ad-lacZ group at the end of the treatment period. The microvessel density of the Ad- vasostatin group was significantly lower than that of the Ad-lacZ group and the PBS group.

Conclusion: The vasostatin gene mediated by adenovirus is efficient for gene therapy for pancreatic carcinoma. The suppression of vasostatin on the proliferation of vasocular endothelium cells and angiogenesis may account for its effect.

Keywords: adenoviral vectors, antiangiogenesis, gene therapy, pancreatic neoplasms, vasostatin


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Digest
Robin Spiller and Alistair Watson
Gut 2006 55: 141. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • Cai, K. X., Tse, L. Y., Leung, C., Tam, P. K.H., Xu, R., Sham, M. H. (2008). Suppression of Lung Tumor Growth and Metastasis in Mice by Adeno-Associated Virus-Mediated Expression of Vasostatin. Clin. Cancer Res. 14: 939-949 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs